Indian Contract Manufacturing - A Hot Opportunity

Table of Contents

1. Analyst View

2. Global Contract Manufacturing Market

• 2.1 Rising Trend of Outsourcing
• 2.2 Market Analysis
  • 2.2.1 Market Size
    • 2.2.1.1 Chemical Synthesis
    • 2.2.1.2 Formulations & Packaging

3. India - Most Potential Contract Manufacturing Destination

• 3.1 Pharma Outsourcing Market
  • 3.1.1 Contract Manufacturing Market
    • 3.1.1.1 Chemical Synthesis
    • 3.1.1.2 Formulation & Packaging
• 3.2 Manufacturing Analysis
  • 3.2.1 Bulk Drugs
  • 3.2.2 Formulations
  • 3.2.3 Drug Packaging
  • 3.2.4 Biopharmaceuticals
• 3.3 Cost Analysis
  • 3.3.1 Employment Cost
  • 3.3.2 Office Rental Cost
  • 3.3.3 Industrial Land Rental Cost
  • 3.3.4 Construction Cost
  • 3.3.5 Cost of Utilities
  • 3.3.6 Freight Cost
• 3.4 Analysis of Human Resources
  • 3.4.1 Pharma Personnel
  • 3.4.2 Pharma-related Degrees
• 3.5 Infrastructure Analysis
  • 3.5.1 Manufacturing
  • 3.5.2 Logistics
  • 3.5.3 ICT
  • 3.5.4 Energy Capacity & Production

4. Industry Analysis

• 4.1 Market Drivers
  • 4.1.1 Increasing Prevalence of Generics
  • 4.1.2 Cost Advantage
  • 4.1.3 Well-developed Infrastructure
  • 4.1.4 Improved IPR Laws
  • 4.1.5 Emerging Pharmaceutical Market
  • 4.1.6 Huge Pool of Human Resources
• 4.2 Opportunities
  • 4.2.1 Supplementary Services in Pharma Outsourcing
  • 4.2.2 Third Party Logistics Market
  • 4.2.3 Pharma Machinery Market
  • 4.2.4 Real Estate Market
• 4.3 Challenges & Threats
  • 4.3.1 Counterfeit Drugs
  • 4.3.2 High Wage Inflation & Attrition
  • 4.3.3 Currency Appreciation
  • 4.3.4 Threats from China

5. Key Players

• 5.1 Divis Laboratories Limited
• 5.2 Dr. Reddy' s Laboratories Limited
• 5.3 Nicholas Piramal India Limited
• 5.4 Jubilant Organosys Healthcare Limited
• 5.5 Shasun Chemicals and Drugs Limited
• 5.6 Dishman Pharmaceuticals & Chemicals Limited

List of Figures:

• Figure 2-1: Global - Contract Manufacturing Market (in Billon US$), 2006 & 2007E
• Figure 2-2: Global - Forecast for Contract Manufacturing Market (in Billon US$), 2008-2012
• Figure 2-3: Global - Contract Manufacturing Market by Type of Manufacturing (%), 2006
• Figure 2-4: Global - Chemical Synthesis Market by In-house & Outsourced Manufacturing (%)
• Figure 2-5: Global - Contract Chemical Synthesis Market (in Billon US$), 2006, 2007E, 2010F & 2012F
• Figure 2-6: Global - Contract Formulations & Packaging Market (in Billlon US$), 2006, 2007E, 2010F & 2012F
• Figure 2-7: Global - Formulations Market by In-house & Outsourced Manufacturing (%)
• Figure 2-8: Global - Contract Dose Manufacturing Market by Type of Drug (%), 2006
• Figure 3-1: India - Pharma Outsourcing Market (in Million US$), 2004-2007E
• Figure 3-2: India - Pharma Outsourcing Market by Segment (%), 2006
• Figure 3-3: India - Forecast for Pharma Outsourcing Market (in Million US$), 2008-2012
• Figure 3-4: India - Contract Manufacturing Market (in Millon US$), 2004-2007E
• Figure 3-5: India - Forecast for Contract Manufacturing Market (in Millon US$), 2008-2012
• Figure 3-6: India - Contract Manufacturing Market by Type of Manufacturing (%), 2006
• Figure 3-7: India - Contract Chemical Synthesis Market (in Millon US$), 2006, 2007E & 2012F
• Figure 3-8: India - Contract Formulations & Packaging Market (in Million US$), 2006, 2007E & 2012F
• Figure 3-9: India - Bulk Drug Production* (in Billion INR), 2001-02 to 2006-07E
• Figure 3-10: India - Formulations Production* (in Billion INR), 2001-02 to 2006-07E
• Figure 3-11: India - Drug Packaging Market (in Billion INR), 2006-07 & 2011-12F
• Figure 3-12: Global - Contract Biopharmaceutical Manufacturing Market (in Billion US$), 2004, 2006 & 2007E
• Figure 3-13: Global - Forecast for Contract Biopharmaceutical Manufacturing Market (in Billion US$), 2008-2012
• Figure 3-14: Global - Biopharmaceutical Manufacturing Market by Segment (%), 2007E
• Figure 3-15: India - Biopharmaceutical Market (in Billion INR), 2002-03 to 2006-07 & 2011-12F
• Figure 3-16: India - Relative Annual Cost of Bioscale-up Manufacturing w.r.t. Other Countries
• Figure 3-17: India - Relative Annual Cost of Secondary Manufacturing w.r.t. Other Countries
• Figure 3-18: India - Office Rental Cost w.r.t Other Countries (in US$/Sq. Metre), 2003
• Figure 3-19: India - Industrial Land Rental Cost w.r.t. Other Countries (in US$/Sq. Metre), 2003
• Figure 3-20: India - Construction Cost w.r.t Other Countries (in US$/Sq. Metre), 2003
• Figure 3-21: India - Number of FDA Approved Plants w.r.t. Other Countries, 2006
• Figure 3-22: India - Cost of Logistics as Percentage of GDP w.r.t. Other Countries, 2006
• Figure 3-23: India - Average Distance Covered by Truck w.r.t. Other Countries (in Km/day), 2006
• Figure 3-24: India - Average Turnaround Time at Ports w.r.t. Other Countries (in Hours), 2006
• Figure 4-1: Global - Generic Market (in Billion US$), 2001-2007E & 2010F
• Figure 4-2: India - Domestic Pharmaceutical Market* (in Billion INR), 2002-03 to 2006-07 & 2011-12F
• Figure 4-3: Global - Supplementary Services in Pharma Outsourcing Market (in Billion US$), 2006 & 2010F
• Figure 4-4: India - Supplementary Services in Pharma Outsourcing Market (in Million US$), 2004, 2006 & 2007E
• Figure 4-5: India - Forecast for Supplementary Services in Pharma Outsourcing Market (in Million US$), 2008-2010
• Figure 4-6: India - Logistics Market (in Billion US$), 2006 & 2010F
• Figure 4-7: India - Outsourced Logistics Market (in Billion US$), 2006 & 2010F
• Figure 4-8: India - Pharma Machinery Market (in Billion INR), 2004, 2007E & 2010F
• Figure 4-9: India - Real Estate Market (in Billion US$), 2006 & 2015F
• Figure 4-10: India - Attrition in Pharma Market w.r.t. Global Level (%), 2005
• Figure 4-11: India - Currency Exchange Rate* (From US$ to INR), 2001-2008

List of Tables:

• Table 3-1: India - Bioscale-up Manufacturing Cost Model w.r.t. Other Countries (in US$)
• Table 3-2: India - Secondary Manufacturing Cost Model w.r.t. Other Countries (in US$)
• Table 3-3: India - Annual Cost of Pharma-related Labor w.r.t. Other Countries (in US$), 2004
• Table 3-4: India - Cost of Utilities (Electricity, Gas, Water, Phone & Internet) w.r.t. Other Countries (in US$), 2004
• Table 3-5: Cost of Freight to & from India w.r.t. Other Countries (in US$), 2004
• Table 3-6: India - Number of Pharmaceutical Personnels w.r.t. Other Countries, 2003E
• Table 3-7: India - Number of Pharma-related Graduate Degrees w.r.t. Other Countries, 2002
• Table 3-8: India - Number of Pharma-related Masters Degrees w.r.t. Other Countries, 2002
• Table 3-9: India - Number of Pharma-related Doctorate & Post Doctorate Degrees w.r.t Other Countries, 2002
• Table 3-10: India - ICT Infrastructure w.r.t. Other Countries, 2007E
• Table 3-11: India - Electricity Capacity & Production w.r.t. Other Countries, 2006
• Table 4-1: India - Estimated Share of Counterfeit Drugs in Pharma Market (%)
• Table 5-1: Divis Laboratories Limited - Key Financials (in Million INR), Mar 2006 & Mar 2007
• Table 5-2: Dr. Reddy' s Laboratories Limited - Key Financials (in Million US$), Mar 2005 to Mar 2007
• Table 5-3: Nicholas Piramal India Limited - Key Financials (in Million INR), Mar 2006 & Mar 2007
• Table 5-4: Jubilant Organosys Healthcare Limited - Key Financials (in Million INR), Mar 2006 & Mar 2007
• Table 5-5: Shasun Chemicals and Drugs Limited - Key Financials (in Million INR), Mar 2006 & Mar 2007
• Table 5-6: Dishman Pharmaceuticals & Chemicals Limited - Key Financials (in Million INR), Mar 2006 & Mar 2007